Polatuzumab vedotin - Genentech
At a glance
- Drug Originator Genentech
- Drug Licenced by Chugai Pharmaceutical
- Drug Class Antineoplastics; Auristatins; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
- USA Patent Applicants GENENTECH
- USA Patents 1
- BLAs 1
Table of Contents
Disclaimer